Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
about
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 systemInterleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor geneMolecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1History of interleukin-4Characterization of the cytoplasmic domain of interleukin-13 receptor-alphaCharacterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activationKinetic analysis of the interleukin-13 receptor complexCharacterization of the interaction between interleukin-13 and interleukin-13 receptorsInduction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytesIncreased expression of cytosolic phospholipase A2, 5-lipoxygenase and 5-lipoxygenase-activating protein in rat peritoneal macrophages during ovalbumin-induced sensitizationJanus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferonsMacrophages redirect phagocytosis by non-professional phagocytes and influence inflammation.A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.How does high-fat diet induce adipose tissue fibrosis?Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor.The role of interleukin-4 and interleukin-13 in the non-immunologic aspects of asthma pathogenesis.On the origin of the triplet puzzle of homologies in receptor heteromers: immunoglobulin triplets in different types of receptors.Specificity of signaling by hematopoietic cytokine receptors: instructive versus permissive effects.Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-10-dependent mechanismDecreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiencyIL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy.STAT6-deficient mice exhibit normal induction of murine AIDS and expression of immunoglobulin E following infection with LP-BM5 murine leukemia virusesRPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyAn IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice.Soluble cytokine receptors: novel immunotherapeutic agents.Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transIL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.Interleukin-4 and interleukin-13: their similarities and discrepancies.IL-13Rα2 has a protective role in a mouse model of cutaneous inflammationCytokine and cytokine receptor pleiotropy and redundancy.Soluble cytokine receptors in biological therapy.Local treatment of brain tumors with targeted chimera cytotoxic proteins.IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.Stimulating IL-13 receptors on T cells: a new pathway for tolerance induction in diabetes?
P2860
Q24310081-D544C822-EEDA-4F7B-B40C-AB45AEEEECD5Q24324698-37397E71-DC88-42EE-A9F6-F49E531186AEQ27660192-F1AC024B-0400-4D33-A1D2-1F8163B41080Q27683911-FDD00F69-1389-4D09-8CD9-7FD3D567191FQ28085747-4AB0B8CF-905C-4F0F-B04E-7422EDEEBAF8Q28139906-D7456486-DA47-4AFF-BCE5-3914A0BB97DBQ28142632-7AD559DD-BEF6-4257-83A2-C244A58AA0C6Q28204543-46F50543-A0FE-4B13-A02F-D786F194FFF9Q28248430-F924AA18-B141-45CF-BD3A-2EB8F7166244Q28289279-1EFAA879-5D80-401E-8EBC-0F21671CF811Q28569958-76B07A7B-F176-4C3E-9CC4-ED4F8581C98BQ28609580-68D645DC-24B1-48B8-9230-467BD8745843Q30275465-38ED7BA4-324A-4208-90A3-AB6C37BBEF2DQ30406072-7E450400-1266-4210-BB73-66A267711E64Q30422423-A559FCDF-8DF2-4089-A9F1-DDD2469E29B1Q30918669-C2950BFB-9BDA-4004-8CE2-8E8E12808E76Q31154987-A6739DDF-7BD1-4869-AA2D-CE1EBC0AEF57Q33352162-3431B2FC-367F-4733-8142-841FCF727BFBQ33540009-3B7F5D27-A789-4A51-9E66-FE0018902DB4Q33557513-082A0ADD-6CCC-4EF4-B08E-EE5594B24235Q33591505-AD7754A4-B796-4BBC-A81D-F8D302DC99A2Q33600721-47695C83-1BCE-4FA4-B9C0-436F28238E81Q33622543-BF401586-804D-44BC-BC1C-D4E7860E29AEQ33654576-AA5D352A-1B74-436F-AAD2-984C067D817DQ33804200-A932BAF2-6976-4C8A-B155-C0974F13B8E9Q33818515-783C52B1-A06A-4F56-813A-5F3394389D46Q33844398-DC4C1F1F-0305-4009-B343-29B71B57A1FFQ33853821-16A04C90-6DEE-4DAF-8C69-CBF90E77B50FQ33994618-F5033BD7-3151-4442-8049-91984F769C32Q34005565-50074467-5476-47FD-941C-5F07110DF43FQ34074749-2C8B855D-BECB-4E65-A395-14B67CBB0D23Q34145976-03F4E27B-DFCD-4D89-AB3B-07EE7D88B47EQ34326427-6A3D3D06-247D-4BE5-990C-0343CCCFB9F4Q34488885-3C907E5E-DC1E-47C5-9803-B6C20F2F2CCEQ34610797-0772BFB6-2053-4B56-A04A-184293A9D539Q34693494-926FF70F-9521-49CB-96EF-1F26F4833372Q34779777-ECC78933-4B0B-4D3B-BB39-4C97F1C74F4CQ34798727-207EA06C-0049-4D8D-A63D-56FD1F9C8C22Q35024839-4C0AA28A-F718-4E06-97A2-B4A72CDD4105Q35043465-98B8409B-77AD-4F63-9CBC-87FB81E61920
P2860
Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Cloning and characterization o ...... of the interleukin 4 receptor
@ast
Cloning and characterization o ...... of the interleukin 4 receptor
@en
type
label
Cloning and characterization o ...... of the interleukin 4 receptor
@ast
Cloning and characterization o ...... of the interleukin 4 receptor
@en
prefLabel
Cloning and characterization o ...... of the interleukin 4 receptor
@ast
Cloning and characterization o ...... of the interleukin 4 receptor
@en
P2093
P2860
P356
P1476
Cloning and characterization o ...... of the interleukin 4 receptor
@en
P2093
T A Willson
W S Alexander
P2860
P304
P356
10.1073/PNAS.93.1.497
P407
P577
1996-01-01T00:00:00Z